Association between Bisphenol A and New York Heart Association classification of heart failure in patients with dilated cardiomyopathy
| Dilated Cardiomyopathy with detected Bisphenol A No: 12 | Dilated Cardiomyopathy with non-detected Bisphenol A No: 38 | Chi-square test | P value | |
|---|---|---|---|---|
| New York Heart Association Class II | 5 (41.7%) | 17 (44.7%) | 2.5 | 0.280 |
| New York Heart Association Class III | 6 (50.0%) | 11 (28.9%) | ||
| New York Heart Association Class IV | 1 (8.3%) | 10 (26.3%) |
Comparison between dilated cardiomyopathy and healthy controls groups regarding the ECG abnormalities_
| Dilated Cardiomyopathy Group No: 50 | Healthy Controls Group No: 30 | Chi-square test | P value | ||
|---|---|---|---|---|---|
| ECG Characteristics | Normal ECG | 25 (50.0%) | 27 (90.0%) | 13.2 | 0.0003 |
| Abnormal ECG including Atrial Fibrillation, Left Bundle Branch Block, and Right Bundle Branch Block | 25 (50.0%) | 3 (10.0%) |
Association between Bisphenol A and volumetric indexes of the left atrial diameter and right ventricular size and function in patients with dilated cardiomyopathy_
| Dilated Cardiomyopathy with detected Bisphenol A No: 12 | Dilated Cardiomyopathy with non-detected Bisphenol A No: 38 | Independent t-test | P value | ||
|---|---|---|---|---|---|
| Left Atrial Diameter Mean ± SD | 40.58 ± 4.34 | 37.39 ± 5.55 | 3.19 | 0.050 | |
| Dilated Cardiomyopathy with detected Bisphenol A | Dilated Cardiomyopathy with nondetected Bisphenol A | Chi-square test | P value | ||
| No: 12 | No: 38 | ||||
| Right Ventricle Size | Dilated Right Ventricle | 9 (75.0%) | 5 (13.2%) | 17.3 | < 0.0001 |
| Normal Right Ventricle | 3 (25.0%) | 33 (86.8%) | |||
| Dilated Cardiomyopathy with detected Bisphenol A | Dilated Cardiomyopathy with nondetected Bisphenol A | Independent t-test | P value | ||
| No: 12 | No: 38 | ||||
| Tricuspid Annular Plane Systolic Excursion Mean ± SD | 14.42 ± 1.93 | 17.58 ± 2.32 | –3.16 | < 0.0001 | |
Comparison between dilated cardiomyopathy and healthy controls groups regarding the baseline characteristics and risk factors_
| Dilated Cardiomyopathy Group No: 50 | Healthy Controls Group No: 30 | Independent t-test | P value | ||
|---|---|---|---|---|---|
| Age Mean ± SD | 56.7 ± 12.8 | 58.2 ± 9.8 | 1.5 | 0.568 | |
| Dilated Cardiomyopathy Group | Healthy Controls Group | Chi-square test | P value | ||
| No: 50 | No: 30 | ||||
| Sex | Females | 13 (26.0%) | 7 (23.3%) | 0.07 | 0.790 |
| Males | 37 (74.0%) | 23 (76.7%) | |||
| Residence | Fayoum | 17 (34.0%) | 10 (33.0%) | 0.004 | 0.951 |
| Other Districts | 33 (66.0%) | 20 (66.7%) | |||
| 0 | 2 (4.0%) | 0 (0.0%) | |||
| No: of Offspring | 2 | 12 (24.0%) | 5 (16.7%) | 1.99 | 0.574 |
| 3 | 13 (26.0%) | 9 (30.0%) | |||
| ≥4 | 23 (46.0%) | 16 (53.3%) | |||
| Diabetes Mellitus | Yes | 9 (18.0%) | 8 (26.7%) | 0.84 | 0.359 |
| No | 41 (82.0%) | 22 (73.3%) | |||
| Hypertension | Yes | 14 (28.0%) | 9 (30.0%) | 0.0366 | 0.848 |
| No | 36 (72.0%) | 21 (70.0%) | |||
| Ex-smokers | 15 (30.0%) | 8 (26.7%) | |||
| Smoking | Smokers | 3 (6.0%) | 5 (16.7%) | 2.37 | 0.306 |
| Non-smokers | 32 (64.0%) | 17 (56.7%) | |||
| Family History | Yes | 9 (18.0%) | 8 (26.7%) | 0.84 | 0.359 |
| No | 41 (82.0%) | 22 (73.3%) | |||
Comparison between dilated cardiomyopathy and healthy controls groups regarding Bisphenol A_
| Dilated Cardiomyopathy Group No: 50 | Healthy Controls Group No: 30 | Chi-square test | P value | |
|---|---|---|---|---|
| Bisphenol A detected | 12 (24.0%) | 2 (6.7%) | 3.9 | 0.048 |
| Bisphenol A not detected | 38 (76.0%) | 28 (93.3%) |